Influence of the co-encapsulation of different excipients on the properties of polyester microparticle-based vaccine against brucellosis

International Journal of Pharmaceutics

Volumn 271, Issue 1-2, 2004, Pages 125-135

  Murillo, M ^a   Irache, J M ^a   Estevan, M ^a   Goni M M ^a   Blasco, J M ^b   Gamazo, C ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Agrifood Institute of Aragón IA2   (Spain)

Author keywords

Brucellosis; Microparticles; Phagocytosis; Poly(lactide co glycolide); Poly( caprolactone); Vaccine

Indexed keywords

BRUCELLA VACCINE; EXCIPIENT; HYDROGEN PEROXIDE; NITRIC OXIDE; POLOXAMER; POLYCAPROLACTONE; POLYESTER; POLYGLACTIN; POLYMER; POLYSORBATE 20; POVIDONE;

ANIMAL CELL; ANTIGENICITY; ARTICLE; BRUCELLA OVIS; BRUCELLOSIS; CELL ACTIVATION; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; ENCAPSULATION; HYDROPHOBICITY; MONOCYTE; MOUSE; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SUSTAINED DRUG RELEASE;

EID: 1142285522     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.11.008     Document Type: Article

References (46)

1. Ahsan F., Rivas I.P., Khan M., Torres Suárez A.I. Targeting to macrophages: role of physicochemical properties of particulate carriers - liposomes and microspheres - on the phagocytosis by macrophages. J. Control. Release. 79:2002;29-40.
2. Artursson P., Arro E., Edman P., Ericsson J.L.E., Sjöholm I. Biodegradable microspheres. V: stimulation of macrophages with microparticles made of various polysaccharides. J. Pharm. Sci. 76:1997;127-133.
3. Babior B.M. The respiratory burst of phagocytes. J. Clin. Invest. 73:1983;599-601.
4. Benoit M.A., Baras B., Guillard J. Preparation and characterization of protein-loaded poly(e-caprolactone) microparticles for oral vaccine delivery. Int. J. Pharm. 184:1999;73-84.
5. Blanco D., Alonso M.J. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur. J. Pharm. Biopharm. 45:1998;285-294.
6. Blasco J.M., Gamazo C., Winter A.J., Marín C., Barberán M., Alonso-Urmeneta B., Jiménez de Bagüés M.P., Moriyón I., Díaz R. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams. Vet. Immunol. Immunopathol. 37:1993;257-270.
7. Blasco J.M., Diaz R. Brucella melitensis Rev.1 vaccine as a cause of human brucellosis. Lancet. 342:1993;805.
8. Bowden R.A., Estein S.M., Zygmunt M.S., Dubray G., Cloeckaert A. Identification of protective outer membrane antigens of Brucella ovis by passive immunisation of mice with monoclonal antibodies. Microbes. Infect. 2:2000;481-488.
9. Cao X., Schoichet M.S. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials. 20:1999;329-339.
10. Cloeckaert A., Verger J.M., Grayon M., Vizcaino N. Molecular and immunological characterization of the major outer membrane proteins of Brucella. FEMS Microbiol. Lett. 15:1996;1-8.
11. Conway M.A., Madrigal-Esteban L., McClean S., Brayden D.J., Mills K.H.G. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells. Vaccine. 19:2001;1940-1950.
12. Corner L.A., Alton G.G. Persistence of Brucella abortus strain 19 infection in adult cattle vaccinated with reduced doses. Res. Vet. Sci. 31:1981;342-344.
13. De Rosa G.D., Iommelli R., La Rotonda M.I., Miro A., Quaglia F. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres. J. Control. Release. 69:2000;283-295.
14. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:1998;2407-2412.
15. Gamazo C., Winter A.J., Moriyón I., Riezu-Boj J.I., Blasco J.M., Díaz R. Comparative analysis of proteins extracted by hot saline or release spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis. Infect. Immun. 57:1989;1419-1426.
16. Gross A., Spiesser S., Terraza A., Rouot B., Caron E., Dornand J. Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages. Infect. Immun. 66:1998;1309-1316.
17. Hilbert A.K., Fritzsche U., Kissel T. Biodegradable microspheres containing influenza A vaccine: immune response in mice. Vaccine. 17:1999;1065-1073.
18. Jackson J.K., Springate C.M.K., Hunter W.L., Burt H.M. Neutrophil activation by plasma opsonized polymeric microspheres: inhibitory effect of Pluronic F127. Biomaterials. 21:2000;1483-1491.
19. Jiménez de Bagués M.P., Elzer P.H., Blasco J.M., Marén C.M., Gamazo C., Winter A.J. Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines. Infect. Immun. 62:1994;632-638.
20. Jiménez de Bagüés M.P., Barberán M., Marín C.M., Blasco J.M. The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams. Vaccine. 13:1995;301-304.
21. Kittelberger R., Hilbink F., Hansen M.F., Ross G.P., de Lisle G.W., Cloeckaert A., de Bruyn J. Identification and characterization of immunodominant antigens during the course of infection with Brucella ovis. J. Vet. Diagn. Invest. 7:1995;210-218.
22. Kreeger T.J., Cook W.E., Edwards W.H., Elzer P.H., Olsen S.C. Brucella abortus strain RB51 vaccination in elk. II. Failure of high dosage to prevent abortion. J. Wildl. Dis. 38:2002;27-31.
23. Lin W.J., Huang L.I. Influence of pluronics on protein-loaded poly(epsilon-caprolactone) microparticles. J. Microencapsulation. 18:2001;191-197.
24. Lopez-Urrutia L., Alonso A., Nieto M.L., Bayon Y., Orduña A., Sanchez Crespo M. Lipopolysaccharides of Brucella abortus and Brucella melitensis induce nitric oxide synthesis in rat peritoneal macrophages. Infect. Immun. 68:2000;1740-1745.
25. Marín C.M., Jiménez de Bagués M.P., Blasco J.M., Gamazo C., Moriyón I., Díaz R. Comparison of three serological tests for Brucella ovis infection of rams using different antigenic extracts. Vet. Rec. 11:1989;504-508.
26. Men Y., Audran R., Thomasin C., Eberl G., Demotz H.P., Gander B., Corradin G. MHC class I- and class II-restricted processing and presentation of microencapsulated antigens. Vaccine. 17:1999;1047-1056.
27. Moore A., McGuirk P., Adams S., Jones W.C., McGee J.P., O'Hagan D.T., Mills K.H. Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic lymphocytes and CD4+ Th1 cells. Vaccine. 13:1995;1741-1749.
28. Morita T., Sakamura Y., Horikiri Y., Suzuki T., Yoshino H. Applicability of various amphiphilic polymers to the modification of protein release kinetics from biodegradable reservoir-type microspheres. Eur. J. Pharm. Biopharm. 51:2001;45-53.
29. Müller R.H., Rühl D., Paulke B.R. Influence of fluorescent labelling of polystyrene particles on phagocytic uptake, surface hydrophobicity, and plasma protein adsorption. Pharm. Res. 14:1997;18-24.
30. Murillo M., Grilló M.J., Reñé J., Marín C.M., Barberán M., Goñi M.M., Blasco J.M., Irache J.M., Gamazo C. A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice. Vaccine. 19:2001;4099-4106.
31. Murillo M., Gamazo C., Irache J.M., Goñi M.M. Polyester microparticles as a vaccine delivery system for brucellosis: influence of the polymer on release, phagocytosis and toxicity. J. Drug Target. 10:2002a;211-219.
32. Murillo M., Goñi M.M., Irache J.M., Arangoa M.A., Blasco J.M., Gamazo C. Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens. J. Control. Release. 85:2002b;237-246.
33. Park T.G., Cohen S., Langer R. Controlled protein release from polyethyleneimine-coated poly(L-lactic acid)/pluronic blend matrices. Pharm. Res. 9:1992;37-39.
34. Prior S., Gander B., Blarer N., Merkle H.P., Subirá M.L., Irache J.M., Gamazo C. In vitro phagocytosis and monocyte activation with poly(lactide) and poly(lactide-co-glycolide) microspheres. Eur. J. Pharm. Sci. 15:2002;197-207.
35. Riezu-Boj J.I., Moriyón I., Blasco J.M., Marín C.M., Díaz R. Comparison of lipopolysaccharide and outer membrane protein-lipopolysaccharide extracts in an enzyme-linked immunosorbent assay for the diagnosis of Brucella ovis infection. J. Clin. Microbiol. 23:1986;938-942.
36. Riezu-Boj J.I., Moriyón I., Blasco J.M., Gamazo C., Díaz R. Antibody response to Brucella ovis outer membrane proteins in ovine brucellosis. Infect. Immun. 58:1990;489-494.
37. Rojas J., Pinto-Alphandary H., Leo S., Pecquet E., Couvreur P., Fattal E. Optimization of the encapsulation and release of β-lactoglobulin entrapped poly(DL-lactide-co-glycolide) microspheres. Int. J. Pharm. 183:1999a;67-71.
38. Rojas J., Alphandary H.P., Leo E., Pecquet S., Couvreur P., Gulik A., Fattal E. A polysorbate-based non-ionic surfactant can modulate loading and release of β-lactoglobulin entrapped in multiphase poly(DL-lactide-co- glycolide) microspheres. Pharm. Res. 16:1999b;255-260.
39. Sanchez A., Villamayor B., Guo Y., McIver J., Alonso M.J. Formulation strategies for the stabilisation of tetanus toxoid in poly(lactide-co-glycolide) microspheres. Int. J. Pharm. 185:1999;255-266.
40. Tibor A., Decelle B., Letesson J.J. Outer membtane proteins Omp10, Omp16, and Omp19 of Brucella spp. are lipoproteins. Infect. Immun. 67:1999;4960-4962.
41. Tobio M., Nolley J., Guo Y., McIver J., Alonso M.J. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle. Pharm. Res. 16:1999;682-688.
42. Torché A.M., Le Corre P., Albina E., Jestin A., Le Verge R. PLGA microspheres phagocytosis by pig alveolar macrophages: influence of poly(vinyl alcohol) concentration, nature of loaded-protein and copolymer nature. J. Drug Target. 7:2000;343-354.
43. Vizcaino N., Cloeckaert A., Zygmunt M.S., Dubray G. Cloning, nucleotide sequence, and expression of the Brucella melitensis omp31 gene coding for an imunogenic major outer membrane protein. Infect. Immun. 64:1996;3744-3751.
44. Yeh M.K., Davis S.S., Coombes A.G.A. Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers. Pharm. Res. 13:1996;1693-1698.
45. Yeh M.K., Liu Y.T., Chen J.L., Chiang C.H. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles. J Control. Release. 82:2002;237-247.
46. Zygmunt M.S., Cloeckaert A., Dubray G. Brucella melitensis cell envelope protein and lipopolysaccharide epitopes involved in humoral immune responses of naturally and experimentally infected sheep. J. Clin. Microbiol. 32:1994;2514-2522.